Source: International Congress 2016 – Pharmacological management of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Dave Singh (Manchester, United Kingdom), Dave Singh, Anthony D. D’Urzo, Ferran Chuecos, Anna Muñoz, Esther Garcia Gil. Reduction in clinically important deterioration in COPD with aclidinium/formoterol. Eur Respir J 2016; 48: Suppl. 60, 301

Member's Comments

No comment yet.

Related content which might interest you: Changes in quality of life and physiological status in newly diagnosed COPD patients Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Pulmonary rehabilitation: Is it feasible and beneficial in mild COPD? Source: International Congress 2016 – Latest insights into pulmonary rehabilitation Year: 2016 Quality of life in obstructive lung diseases Source: Annual Congress 2013 –Various issues in clinical respiratory physiology Year: 2013 Impact of lung function impairment and exacerbation history on COPD patient-reported utility Source: International Congress 2014 – COPD markers Year: 2014 Predictive role of mMRC scale on quality of life in COPD patients Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2) Year: 2013 Effectiveness of a 3-week-in-patient-rehabilitation-program in patients with COPD GOLD-stage IV Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1) Year: 2013 Factors associated with outcome among COPD patients undergoing pulmonary rehabilitation Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2) Year: 2013 The pulmonary artery-aorta ratio, exacerbation rate and quality of life in stable COPD patients Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Fatigue and decreased health can predict mortality in COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Which are the main determinants of quality-of-life in severe asthma? Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Impaired health status in primary care COPD patients is underestimated Source: International Congress 2015 – Respiratory disease management in primary care Year: 2015 Longitudinal changes in COPD patients in primary care Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Discordant symptom severity in COPD: The PHAROAH study Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Effect of roflumilast on quality of life in frequent and infrequent exacerbators Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Relationship between clinical impact of the disease and postural balance in COPD patients Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease Year: 2016 The use of high-freguency chest-wall compression therapy for COPD patients Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities Year: 2013 Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Modelling the long-term effects of an active case finding programme for undiagnosed COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 The impact of exacerbations on adherence and outcomes of pulmonary rehabilitation in patients with COPD Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases Year: 2016 Quality of life (QL) depending on psychological disorders (PD) of patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Comorbidities Year: 2014